About two thirds of breast cancers are classified as “hormone receptor positive” disease. These cancer cells express a group of proteins that bind to hormones, including estrogen and progesterone, ...

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a neurokinin-targeted therapy, reduces the ...

Please provide your email address to receive an email when new articles are posted on . Among patients with breast cancer in China, those who underwent adjuvant endocrine therapy had more prevalent ...

New awareness BCYWF articles explain how age, tumor subtype, fertility, and endocrine therapy influence diagnosis, ...

In women with breast cancer vasomotor and joint symptoms are common adverse effects of endocrine treatment. Some studies have indicated that the development of vasomotor symptoms is associated with ...

The is a summary of a study published as a preprint on ResearchSquare.com. It has not yet been peer reviewed. Adjuvant endocrine therapies for hormone receptor-positive (HR+) breast cancer, including ...

The association of a treatment-related adverse effect with treatment success has been reported in various clinical situations. The development of vasomotor or joint symptoms is an indication of ...

This is a young woman with node-positive breast cancer. Currently, she is receiving combined endocrine therapy with tamoxifen and a gonadotropin-releasing hormone (GnRH)-agonist, goserelin, to ...

Symptoms of polycystic ovary syndrome (PCOS) improved with exposure to healthy bacteria in the gut, according to a study in a mouse model of this common women's endocrine disorder. Symptoms of ...